Chronic Renal Insufficiency, Itch, Pruritus
Conditions
Keywords
itch, pruritus, nursing, virtual reality
Brief summary
The research will be conducted randomly in order to determine the effect of VR and AR on pruritus symptom.
Detailed description
In this study, there will be three groups: intervention group 1 with autogenic relaxation (AR), intervention group 2 with virtual reality (VR) game application and control group with routine nursing care and kidney functions narration. The number of volunteers to be included in the study was determined by power analysis. Forty patients with itch symptoms will be included in each group. Preliminary application for all three groups will be performed in the patient group registered to the Dialysis Unit of the Nephrology Department of Hacettepe University and Baskent University Hospital. Socio-Demographic Form, 5-D Itch Scale, Dermatology Life Quality Index, State and Trait Anxiety Scale, Pruritus Behavior and SGO / OR Application Log.
Interventions
OTHERAutogenic Relaxation
Autogenic relaxation
OTHERvirtual reality game application
virtual reality game application,
OTHERkidney function narration
kidney function narration
Sponsors
Baskent University
Hacettepe University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Receiving hemodialysis treatment for the last 6 months, * Receiving four hour hemodialysis treatment three times a week, * 18-65 years of age, * experiencing pruritus for the last month. * Not taking any pharmacological / non-pharmacological treatment for pruritus * No cognitive and psychiatric diagnosis, * Do not use hearing aids, * Open to communication and cooperation, * Using smart mobile phone, * Without liver disease and dermatological diseases, * Patients who agree to participate in the study will be included in the study.
Exclusion criteria
* Pregnant in the research process, * Kidney transplantation, * Experiencing discomfort due to virtual reality glasses, * Patients who voluntarily leave the trial will be excluded from the follow-up.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 5-D Itch Scale | Assessing change of 5-D Itch Scale scores baseline, first, fifth and seventh weeks. | The score obtained from information about itching severity, frequency, and its effect on daily life activities. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Dermatology Life Quality Index | Assessing change of Dermatology Life Quality Index scores baseline, first, fifth and seventh weeks. . | The scale gives an information about quality of life |
| State-Trait Anxiety Inventory | Assessing change of State-Trait Anxiety Inventory scores baseline, first, fifth and seventh weeks. | The scale gives an information about anxiety |
Countries
Turkey (Türkiye)
Outcome results
None listed